Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 375 of 3546 entries
View as:

A Study of GW856553X For the Treatment of Depression

Phase: N/A Priority: Normal
NCT ID: NCT00569062 Org: User:
Start: 09/12/07 End: 06/25/08 Due: 06/25/09

An Efficacy Study of Stain Control of a 67% Sodium Bicarbonate Containing Toothpaste on Chlorhexidine Tooth Staining

Phase: N/A Priority: Normal
NCT ID: NCT01962493 Org: User:
Start: 09/30/13 End: 11/30/13 Due: 11/30/14

Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00127608 Org: User:
Start: 06/07/05 End: 07/13/06 Due: 07/13/07

Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00603525 Org: User:
Start: 01/31/08 End: 07/31/13 Due: 07/31/14

Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT03980483 Org: User:
Start: 05/16/19 End: 08/16/22 Due: 08/16/23

A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding Phase

Phase: N/A Priority: Normal
NCT ID: NCT00528281 Org: User:
Start: 09/20/07 End: 05/27/09 Due: 05/27/10

Bioequivalence Trial of Alprazolam 2 mg Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01745575 Org: User:
Start: 03/28/10 End: 04/05/10 Due: 04/05/11

A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants

Phase: N/A Priority: Normal
NCT ID: NCT04316585 Org: User:
Start: 09/28/20 End: 10/12/21 Due: 10/12/22

A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT00483860 Org: User:
Start: 06/20/07 End: 02/06/12 Due: 02/06/13

Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9

Phase: N/A Priority: Normal
NCT ID: NCT00489970 Org: User:
Start: 06/01/07 End: 03/01/16 Due: 03/01/17

Exploratory Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity

Phase: N/A Priority: Normal
NCT ID: NCT01831817 Org: User:
Start: 01/31/13 End: 05/31/13 Due: 05/31/14

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK3862995B Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and European Ancestry

Phase: N/A Priority: Normal
NCT ID: NCT06979518 Org: User:
Start: 05/20/25 End: 04/27/26 Due: 04/27/27

A Study to Measure the Sun Protection Factor (SPF) and Ultraviolet-A Protection Factor (UVAPF) of Four Developmental Sunscreen Formulations

Phase: N/A Priority: Normal
NCT ID: NCT03157583 Org: User:
Start: 06/21/17 End: 07/07/17 Due: 07/07/18

A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT03474081 Org: User:
Start: 03/29/18 End: 07/17/19 Due: 07/17/20

Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00126984 Org: User:
Start: 07/31/05 End: 02/29/08 Due: 02/28/09

Dental Plaque Removal Ability of Prototype Power Toothbrush Versus a Manual Toothbrush in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03809910 Org: User:
Start: 07/08/19 End: 08/09/19 Due: 08/09/20

Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00354666 Org: User:
Start: 09/30/04 End: 12/31/04 Due: 12/31/05

Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Versus Menactra® in Healthy Adolescents/Adults

Phase: N/A Priority: Normal
NCT ID: NCT01165242 Org: User:
Start: 08/19/10 End: 07/29/11 Due: 07/29/12

A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study

Phase: N/A Priority: Normal
NCT ID: NCT03355820 Org: User:
Start: 02/28/18 End: 06/29/18 Due: 06/29/19

Qualitative Research to Explore Treatment Preference in Pulmonary Arterial Hypertension (PAH) Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03304548 Org: User:
Start: 11/22/17 End: 04/10/18 Due: 04/10/19

Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications

Phase: N/A Priority: Normal
NCT ID: NCT00158834 Org: User:
Start: 11/30/99 End: - Due: -

Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT01777308 Org: User:
Start: 05/03/13 End: 04/20/16 Due: 04/20/17

All Japanese Population: Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06956170 Org: User:
Start: 02/10/22 End: 11/30/29 Due: 11/30/30

TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)

Phase: N/A Priority: Normal
NCT ID: NCT00387881 Org: User:
Start: 09/30/06 End: 02/29/08 Due: 02/28/09

Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT02690181 Org: User:
Start: 03/29/16 End: 11/02/16 Due: 11/02/17